Principal Investigators: Dr. James Young, Dr. Max Fitzgerald

Disease: MS, Parkinson's, stroke, traumatic brain injury

Research Description: Neurological conditions (including MS, Parkinson’s disease, stroke and traumatic brain injury) cause mobility impairment that is described by patients as the most intrusive symptoms impacting their quality of life. A form of electric stimulation administered with a device placed on the tongue has been studied for many years in patients with a variety of neurological disabilities. A portable version of the device, referred to as the Portable Neuromodulation Stimulator or PoNS, is being repurposed experimentally to improve gait and balance difficulties for people with these neurological disabilities. In this pilot study, Drs. Young and Fitzgerald are evaluating the effectiveness of combining the PoNS device with customized exercise/therapy routines to improve gait and balance for MS and Parkinson’s patients with moderate difficulties with mobility. They also expect to see other potential benefits to mood, quality of life and other functional aspects of daily living.

CWR funding role: Primary funder

CWR Start date: October 2015

Sign up for our eNewsletter today!


First Name

Cures Within Reach

All funds donated to Cures Within Reach may be tax deductible for federal income tax purposes.  CWR is recognized by the IRS as a 501(c)3 tax-exempt not-for-profit organization, tax ID 20-3620169.


Tuesday the 20th. Copyright 2018 Cures Within Reach.